Skip to main content
Have a personal or library account? Click to login
Antigen expression on recurrent meningioma cells Cover

Antigen expression on recurrent meningioma cells

Radiology and Oncology
Volume 44 (2010): Issue 2 (June 2010)
By:   
Open Access
|May 2010
References

References

  1. Ayerbe J, Lobato RD, Cruz J, Cabrera A. Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis.1999; 141: 921-32.
    Open DOISearch in Google Scholar
  2. Black P. 643 meningiomas: current perspective.2003; 32: 643-57.
    Open DOISearch in Google Scholar
  3. De Monte F, Marmor E, Al-Mefty O. Meningiomas. In: Kaye AH, editor.. London: Harcourt Publishers; 2001. p. 719-50.
    Search in Google Scholar
  4. Jäaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A mutivariate analysis.1986; 26: 461-9.
    Open DOISearch in Google Scholar
  5. Franko A, Holjar-Erlic I, Miletic D. Lateral ventricle epidermoid.2008; 42: 66-8.
    Open DOISearch in Google Scholar
  6. Strojan P. Role of radiotherapy in melanoma management.2010; 44: 1-12.
    Open DOISearch in Google Scholar
  7. Torp SH, Lindboe CF, Gronberg BH, Lydersen S, Sundstrom S. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.2005; 24: 170-4.
    Search in Google Scholar
  8. Perry A, Stafford LS, Scheithauer BW, Suman VJ, Lohse CM. The prognostic significance of MIB-1, p53 and DNA flow citometry in completely resected primary meningiomas.1998; 82: 2262-9.
    Open DOISearch in Google Scholar
  9. Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.2004; 146: 37-44.
    Open DOISearch in Google Scholar
  10. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features.1993; 33: 212-8.
    Open DOISearch in Google Scholar
  11. Hsu DW, Efird J, Hedley-White ET. Progesterone and estrogene receptors in meningiomas: prognostic considerations.1997; 86: 113-20.
    Open DOISearch in Google Scholar
  12. Konstantinidou AE, Korkolopoulou P, Mahera H, Kotsiakis X, Hranioti S, Eftychiadis C, et al. Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival.2003; 43: 280-90.
    Open DOISearch in Google Scholar
  13. Friend KE, Radinsky R, McCutcheon IE. Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist.1999; 91: 93-9.
    Open DOISearch in Google Scholar
  14. Hancq S, Salmon I, Brotchi J, De Witte O, Gabius HJ, Heizmann CW, et al. S100A5: a marker of recurrence in WHO grade I meningiomas.2004; 30: 78-87.
    Open DOISearch in Google Scholar
  15. Katoh M, Wilmotte R, Belkouch MC, de Tribolet N, Pizzolato G, Dietrich PY. Survivin in brain tumours: an attractive target for immunotherapy.2003; 64: 71-6.
    Open DOISearch in Google Scholar
  16. Loussouarn D, Brunon J, Avet-Loiseau H, Campone M, Mosnier JF. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.2006; 37: 415-21.
    Open DOISearch in Google Scholar
  17. Puduvalli VK, Li JT, Chen L, McCutcheon IE. Induction of apoptosis in primary meningioma cultures by fenretinide.2005; 65: 1547-53.
    Open DOISearch in Google Scholar
  18. Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao S. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas.2004; 66: 29-37.
    Open DOISearch in Google Scholar
  19. Perret AG, Duthel R, Fotso MJ, Brunon J. Stromelysin-3 is expressed by aggressive meningiomas.2002; 94: 765-72.
    Open DOISearch in Google Scholar
  20. Mikkelsen T, Yan PS, Ho KL, Sameni M. Immunolocalization of cathepsin B in human glioma: implications for tumor invasiveness and angiogenesis.1995; 83: 285-90.
    Open DOISearch in Google Scholar
  21. Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Rao JS. Overexpression and localization of cathepsin B during the progression of human gliomas.1995; 13: 49-56.
    Open DOISearch in Google Scholar
  22. Sivaparvathi M, Yamamoto M, Nicolson GL, Rao JS. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.1996; 14: 27-34.
    Open DOISearch in Google Scholar
  23. Strojnik T, Kos J, Židanik B, Lah TT. Cathepsin B immunohistochemical staining in tumor and endothelial cells is new prognostic factor in patients with brain tumors.1999; 5: 559-67.
    Search in Google Scholar
  24. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies.2008; 42: 69-81.
    Open DOISearch in Google Scholar
  25. Castilla EA, Prayson RA, Abramovich CM, Cohen ML. Immunohistochemical expression of cathepsin D in meningiomas.2003; 119: 123-8.
    Open DOISearch in Google Scholar
  26. Trinkaus M, Vranic A, Dolenc VV, Lah TT. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.2005; 20: 50-9.
    Open DOISearch in Google Scholar
  27. Trinkaus M, Vranic A, Dolenc VV, Lah TT. Cathepsin L in human meningiomas.2003; 37: 89-99.
    Search in Google Scholar
  28. Strojnik T, Zidanik B, Kos J, Lah TT. Cathepsins B and L are markers for clinically invasive types of meningiomas.2001; 48: 598-605.
    Open DOISearch in Google Scholar
  29. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.1999; 85: 2046-56.
    Search in Google Scholar
  30. Modha A, Gutin PH: Diagnosis and treatment of atypical and malignant meningiomas: a review.2005; 57: 538-50.
    Open DOISearch in Google Scholar
  31. Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.2008; 79: 574-80.
    Open DOISearch in Google Scholar
  32. Nordqvist ACS, Smurawa H, Mathiesen T. Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema.2001; 95: 839-84.
    Open DOISearch in Google Scholar
  33. Strojnik A. Search of the shortest regimen: fractionation of a fully isoeffective combination of hyperfractionated and hypofractionated treatment.2008; 42: 170-2.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-010-0028-6 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 107 - 112
Published on: May 24, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
meningioma,
recurrence,
tumour markers,
proliferation index,
MIB-1 antigen,
cathepsin B,
cathepsin L
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2010 Andrej Vranic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 2 (June 2010)
Previous article
Next article